Drug name - Epiduo Forte

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8785420 GALDERMA LABS Combination/association of adapalene and benzoyl peroxide for treating acne lesions Dec, 2022

(2 months from now)

US8936800 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Dec, 2022

(2 months from now)

US9814690 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Dec, 2022

(2 months from now)

US8809305 GALDERMA LABS Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris Dec, 2022

(2 months from now)

US8445543 GALDERMA LABS Combinations of adapalene and benzoyl peroxide for treating acne lesions Dec, 2022

(2 months from now)

US9387187 GALDERMA LABS Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar, 2023

(5 months from now)

US9381179 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar, 2023

(5 months from now)

US8703820 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar, 2023

(5 months from now)

US8729127 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar, 2023

(5 months from now)

Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient

Treatment: Treatment of acne

Dosage: GEL;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.3%;2.5% GEL;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.